Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × liposomal doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 90 Breast Neoplasms 68 Fallopian Tube Neoplasms 36 Multiple Myeloma 26 Carcinoma, Ovarian Epithelial 24 Neoplasms 22 Triple Negative Breast Neoplasms 13 Lymphoma 13 Sarcoma 12 Neoplasm Metastasis 11 Lymphoma, Large B-Cell, Diffuse 9 Recurrence 8 Lymphoma, Non-Hodgkin 7 Hodgkin Disease 7 Prostatic Neoplasms 6 Pancreatic Neoplasms 5 Neoplasms, Plasma Cell 5 Burkitt Lymphoma 5 Solid Tumors 4 Sarcoma, Kaposi 4 Sarcoma, Ewing 4 Lymphoma, T-Cell, Peripheral 4 Carcinoma 4 Breast Neoplasms, Male 4 Uterine Cervical Neoplasms 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Lymphoma, T-Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3

Interventions

Fluorouracil 202 Leucovorin 186 Oxaliplatin 181 Irinotecan 137 Bevacizumab 101 Capecitabine 83 Cetuximab 79 Folfox protocol 52 Chemotherapy, Adjuvant 33 Panitumumab 28 Colonoscopy 27 pembrolizumab 22 Drug Therapy 20 Blood Specimen Collection 20 Floxuridine 19 Nivolumab 18 Gemcitabine 18 Radiotherapy 17 IFL protocol 17 Magnetic Resonance Spectroscopy 16 Laparoscopy 16 Immunohistochemistry 16 Surveys and Questionnaires 15 Exercise 15 Early Intervention, Educational 15 Celecoxib 15 Neoadjuvant Therapy 14 Cyclophosphamide 14 Biopsy 14 trifluridine tipiracil drug combination 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01464593 2022-10-13

ABLATE

Imunon

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡